Therapha is a research and innovation-oriented healthcare technology company registered in New York. It is founded, funded and managed by a group of highly motivated enthusiastic spinecare experts who replicate their everyday success to bring sweeping changes across the globe through digital technology. Consistent with their work, persistent in their mission, tenacious in vision they brought forth TheraphaTM - ‘Practice the Future’. Our patented digital solution is a catalytic bridge between patients and their clinicians to standardize Spinecare and the musculoskeletal world.

Obsidio, Inc. is an early-stage medical device company focused on developing a minimally-invasive occlusive agent using a shear-thinning biomaterial (STB) technology for applications in vascular embolotherapy.

An overview of an AI based SaaS platform for personalized management of seizures using wearables for closed loop monitoring of vital parameters and other neurological biomarkers will be presented. The AI engine provides continuous insights leading to seizure detection and preemptive alert notifications.  Insights provided to the neurologists help them personalize treatment plans by guiding drug titration, detecting tachyphylaxis and managing treatment aggressiveness for better health outcomes.

blinkpad is an AI-driven opportunity matching platform, serving the healthcare and hospitality industries. blinkpad helps employers reduce candidate screening times and time-to-hire by providing high-quality candidate matching. blinkpad maps candidates’ multimedia profiles against unique knowledge graphs of over 50,000 industry-specific specializations. In this way, we match employers with candidates who meet their certification, experience, and schedule requirements. All in the blink of an eye.

The Solution: Improve, fix, or redesign the systems using the New Agreements Transformational Model and 7 Tools, employing a bottom/up, fully participatory, systems-based, “pull” strategy. Solutions to persistent problems require a shift in paradigm or thinking. Employees working within a broken system often attempt to resolve the problems with a reactive, non-systems-based approach. This is akin to trying to solve problems with the same thinking used to create them, which Albert Einstein describes as impossible. This means our problem-solving model or paradigm must change radically, and that is exactly what the New Agreements Model and 7 Tools do for those who master it.

A digital assistant powered by Artificial Intelligence, embedded in a modern care delivery platform, designed to address mental health care delivery challenges at a global scale. HealMed automates patient intake evaluation through touch-free, voice-enabled interface and provides a carefully written summary to providers. The HealMed platform can automate workload up to 75-80%, thereby helping providers spend meaningful time with their clients and delivering great care to them.

UpLyft™ is the first seated self-transfer & 'zero-lifting' system between bed and wheelchair for individuals with limited mobility. Institutional healthcare facilities deal with burgeoning workers compensation claims from back and neck injuries to U.S. healthcare workers due to patient-lifting, which currently eclipse ~$20B annually. UpLyft solves this problem by replacing slings, body boards and other lift systems that require physical force from nurses and caregivers during patient transfers.

Bridge has fixed the delivery problem with buprenorphine that makes it a challenge in practice to use for pain and addiction. Current formulations dissolve in ~10 minutes through the buccal mucosa.  We have licensed 3-second dissolve technology used in 15 major drugs (eg, Nurtec) which is also cheaper to produce. A range of doses will allow use of this drug for chronic pain and also for postoperative pain, which would mean patients would leave hospital with ZERO morphine milligram equivalents.

Elevate your standard of care & patient safety

Whether you are on the frontline, serving as a team lead or a hospital executive, the Elemeno approach gives everyone peace of mind that best practices are being followed in the moment. Elemeno is an all-in-one team training and communication platform that improves safety and retention at the unit level, in addition to elevating interprofessional collaboration. The result: a frontline team that feels supported, confident and competent.

HealthPals is pioneering Precision Prevention. Individuals and patients should be identified and treated effectively before costly, life-altering events happen. Our platform CLINT uses Medical Science and Machine Learning to automate and personalize treatment pathways at an individual and population level -- producing actionable, evidence-based insights about what should be done clinically, when, and why. We have run CLINT through over 1.4 billion patient life-years of medical record data and work with some of the largest and most respected health systems, medical societies, pharma companies, and technology partners. We are VC backed.

The Torque3 platform is a robotic assisted simulator where the patient works their entire body, all of their senses and cognitive abilities during treatment. This experience-dependent multimodal integration engages distributed functional brain regions including the sensory, association and motor cortexes.

RE-INVENTING THE PRESCRIPTION EXPERIENCE

Prescription Fulfillment Services & Solutions for Pharmacies & Healthcare Prescribers

The CME Requirements and ongoing credentialing process are inefficient and flawed. Requirements are due on an asynchronous timeline with complex regulations, which creates a heavy administrative burden on the healthcare systems, clinicians and administrators. The CME process can be streamlined and simplified into two steps. We will present a solution that can help administrators and clinicians to automate the process of managing state licenses, board certifications, to other expiring credentials

Intrommune Therapeutics is developing products to desensitize people living with food allergies using the oral mucosal immunotherapy (OMIT) platform. Our first product, INT301, delivers peanut proteins to the immune system in a fully-functional toothpaste, so the individual receives therapy while brushing their teeth. Intrommune expects that this platform will prove safe, effective and convenient. A Phase I study in peanut allergic individuals is currently ongoing.

Sirica Therapeutics has combined Advanced Robotics and Virtual Reality to develop a therapeutic device for Autism. The robotic machine provides a challenging gross motor activity. And virtual reality provides deeply immersive experiences. The combination of which is being used to develop task-oriented therapy for autism that is fun for the patient. The therapy can be remotely monitored by a specialist. Data from several machines can be combined to build algorithms to improve patient outcomes.

Emergency Departments (EDs) must be ready to treat any patient at any time. They handle highly variable patient arrivals that are difficult for humans to anticipate. Even with good predictions many EDs struggle to match demand. We propose a machine learning system that forecasts the distribution of patient arrivals on an hourly basis at multiple horizons. Using the forecasts, it generates optimal staffing blocks with user-set constraints like target patients per hour or available staff hours.

There are NO approved FDA treatments for late stage COVID infection.  Dexamethasone provides modest benefit in these cases.  This means that if you are an unfortunate victim of the virus that gets sick enough to need oxygen there is a limit in what current standard of care can do for you.  Our drug halts the final pathway of COVID that causes death.  It presses the “off switch”.  In addition to treating late-stage COVID, we have filed patents for use in treating multiple other diseases.